Zh D Kobalava - JoVE Visualize

Showing results (71-80 of 95) with videos related to

Pageof 10

Sort By:

Terapevticheskii Arkhiv|January 1, 1997

[Fosinorm in the treatment of essential hypertension with a metabolic syndrome]Zh D Kobalava, Iu V Kotovskaia, O N Moryleva, et al.

Kardiologiia|September 19, 2019

[Office and 44-hour ambulatory blood pressure and central haemodynamic parameters in the patients with end-stage renal diseases undergoing haemodialysis]M A Trukhanova, A V Orlov, V V Tolkacheva, et al.

Kardiologiia|October 19, 2004

[Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension]Iu V Kotovskaia, N Kh Bagmanova, A S Mil'to, et al.

Kardiologiia|August 10, 2019

[Pulmonary congestion by lung ultrasound in decompensated heart failure: associations, in-hospital changes, prognostic value]Zh D Kobalava, A F Safarova, A E Soloveva, et al.

Kardiologiia|December 17, 2008

[Disproportionately high left ventricular myocardial mass in patients with arterial hypertension]Zh D Kobalava, Iu V Kotovskaia, A F Safarova, et al.

Terapevticheskii Arkhiv|January 1, 1991

[The specificity of the hypotensive effect of calcium antagonists in hypertension]A Ia Ivleva, Zh D Kobalava, I D Antiia, et al.

Kardiologiia|March 16, 2017

[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Kardiologiia|December 23, 2015

[First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Terapevticheskii Arkhiv|March 12, 2005

[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension]Zh D Kobalava, V V Tolkacheva, I V Ignat'ev, et al.

Kardiologiia|June 9, 2005

[Clinical genetic determinants of carbohydrate metabolism disturbances in patients with hypertension and excessive weight]Zh D Kobalava, V V Nosikov, V V Tolkacheva, et al.

Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:

Pageof 10

Terapevticheskii Arkhiv|January 1, 1997

[Fosinorm in the treatment of essential hypertension with a metabolic syndrome]Zh D Kobalava, Iu V Kotovskaia, O N Moryleva, et al.

Kardiologiia|September 19, 2019

[Office and 44-hour ambulatory blood pressure and central haemodynamic parameters in the patients with end-stage renal diseases undergoing haemodialysis]M A Trukhanova, A V Orlov, V V Tolkacheva, et al.

Kardiologiia|October 19, 2004

[Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension]Iu V Kotovskaia, N Kh Bagmanova, A S Mil'to, et al.

Kardiologiia|August 10, 2019

[Pulmonary congestion by lung ultrasound in decompensated heart failure: associations, in-hospital changes, prognostic value]Zh D Kobalava, A F Safarova, A E Soloveva, et al.

Kardiologiia|December 17, 2008

[Disproportionately high left ventricular myocardial mass in patients with arterial hypertension]Zh D Kobalava, Iu V Kotovskaia, A F Safarova, et al.

Terapevticheskii Arkhiv|January 1, 1991

[The specificity of the hypotensive effect of calcium antagonists in hypertension]A Ia Ivleva, Zh D Kobalava, I D Antiia, et al.

Kardiologiia|March 16, 2017

[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Kardiologiia|December 23, 2015

[First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]Zh D Kobalava, E P Pavlikova, O A Averkov, et al.

Terapevticheskii Arkhiv|March 12, 2005

[Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension]Zh D Kobalava, V V Tolkacheva, I V Ignat'ev, et al.

Kardiologiia|June 9, 2005

[Clinical genetic determinants of carbohydrate metabolism disturbances in patients with hypertension and excessive weight]Zh D Kobalava, V V Nosikov, V V Tolkacheva, et al.

Pageof 10